409 related articles for article (PubMed ID: 18826546)
1. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008.
Gazzard BG; Anderson J; Babiker A; Boffito M; Brook G; Brough G; Churchill D; Cromarty B; Das S; Fisher M; Freedman A; Geretti AM; Johnson M; Khoo S; Leen C; Nair D; Peters B; Phillips A; Pillay D; Pozniak A; Walsh J; Wilkins E; Williams I; Williams M; Youle M;
HIV Med; 2008 Oct; 9(8):563-608. PubMed ID: 18826546
[No Abstract] [Full Text] [Related]
2. [Antiretroviral therapy in 2004].
Jablonowski H
MMW Fortschr Med; 2004 Apr; 146 Spec No 1():46-8, 50-1. PubMed ID: 15373049
[TBL] [Abstract][Full Text] [Related]
3. Darunavir: after multiple antiretroviral treatment failure: another option.
Prescrire Int; 2008 Jun; 17(95):109. PubMed ID: 18629967
[TBL] [Abstract][Full Text] [Related]
4. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
;
Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
[No Abstract] [Full Text] [Related]
5. Managing HIV/AIDS patients.
Paul SM; Sensakovic J; Podhurst LS; Morgan DH; Triano-Davis W
N J Med; 1998 May; 95(5):55-60. PubMed ID: 16013158
[No Abstract] [Full Text] [Related]
6. [Guidelines for antiretroviral therapy of human immunodeficiency virus (HIV)-infected subjects in the Czech Republic].
Sedlácek D; Stanková M; Machala L; Rozsypal H; Snopková S; Dostál V; Kolcáková J; Dlouhý P; Jerhotová Z
Klin Mikrobiol Infekc Lek; 2007 Feb; 13(1):28-34. PubMed ID: 17417753
[TBL] [Abstract][Full Text] [Related]
7. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy.
Pozniak A; Gazzard B; Anderson J; Babiker A; Churchill D; Collins S; Fisher M; Johnson M; Khoo S; Leen C; Loveday C; Moyle G; Nelson M; Peter B; Phillips A; Pillay D; Wilkins E; Williams I; Youle M;
HIV Med; 2003 Oct; 4 Suppl 1():1-41. PubMed ID: 14511246
[No Abstract] [Full Text] [Related]
8. Toxicities of antiretroviral therapy in children.
Nwaobasi E; Oleske JM
AIDS Read; 2006 Oct; 16(10):537-40, 544-6,549-50, 552-4. PubMed ID: 17096472
[TBL] [Abstract][Full Text] [Related]
9. German-Austrian recommendations for the antiretroviral therapy of HIV-infection (status May 2004).
Salzberger B; Marcus U; Vielhaber B; Arasteh K; Gölz J; Brockmeyer NH; Rockstroh J
Eur J Med Res; 2004 Nov; 9(11):491-504. PubMed ID: 15649858
[TBL] [Abstract][Full Text] [Related]
10. Persistent differences in the antiviral effects of highly active antiretroviral therapy in the blood and male genital tract.
Pasquier CJ; Moinard N; Sauné K; Souyris C; Lavit M; Daudin M; Izopet J; Bujan L
AIDS; 2008 Sep; 22(14):1894-6. PubMed ID: 18753873
[No Abstract] [Full Text] [Related]
11. [Antiretroviral therapy suppression: already a new strategy?].
Viciana Fernández P; Mata Alcázar-Caballero R; López Cortés LF
Farm Hosp; 2004; 28(6 Suppl 1):85-91. PubMed ID: 15649120
[No Abstract] [Full Text] [Related]
12. [Revised guideline "Antiretroviral Treatment"].
Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren
Ned Tijdschr Geneeskd; 2005 Oct; 149(43):2399-405. PubMed ID: 16277129
[TBL] [Abstract][Full Text] [Related]
13. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
14. The long-term consequences of antiretroviral therapy.
Smith D
J HIV Ther; 2006 Jun; 11(2):24-5. PubMed ID: 16981592
[No Abstract] [Full Text] [Related]
15. Raltegravir-based highly active antiretroviral therapy has beneficial effects on the renal function of human immunodeficiency virus-infected patients after solid organ transplantation.
Moreno A; Pérez-Elías MJ; Casado JL; Fortún J; Bárcena R; Quereda C; Del Campo S; Gutiérrez C; Pastor O; Nuño J; Fernandez A; Moreno S
Liver Transpl; 2010 Apr; 16(4):530-2. PubMed ID: 20213666
[No Abstract] [Full Text] [Related]
16. Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions.
Soriano V; Rivas P; Nuñez M
Clin Infect Dis; 2008 Dec; 47(11):1486-9. PubMed ID: 18937578
[No Abstract] [Full Text] [Related]
17. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
Kwara A; Flanigan TP; Carter EJ
Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral medication errors among hospitalized patients with HIV infection.
Rastegar DA; Knight AM; Monolakis JS
Clin Infect Dis; 2006 Oct; 43(7):933-8. PubMed ID: 16941379
[TBL] [Abstract][Full Text] [Related]
19. Treatment interruption in HIV therapy: a SMART strategy?
Jülg B; Goebel FD
Infection; 2006 Jun; 34(3):186-8. PubMed ID: 16804667
[TBL] [Abstract][Full Text] [Related]
20. HIV/AIDS pathogenesis and treatment options focusing on the viral entry inhibitors.
Jones R; Gazzard B
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):303-12. PubMed ID: 16597210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
